Media coverage
14
Media coverage
Title Vaxalto Biotherapeutics And Mount Sinai Enter Into Exclusive License Agreement For The Development And Commercialization Of Novel Immunotherapeutic Oncolytic Viruses For Treatment Of Cancer Media name/outlet TheStreet.com Country/Territory United States Date 3/03/21 URL https://www.thestreet.com/press-releases/vaxalto-biotherapeutics-and-mount-sinai-enter-into-exclusive-license-agreement-for-the-development-and-commercialization-of-novel-immunotherapeutic-oncolytic-viruses-for-treatment-of-cancer-15584744 Persons Mihaela Skobe, Adolfo Garcia-Sastre, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer Media name/outlet Canada NewsWire Country/Territory Canada Date 3/03/21 Persons Mihaela Skobe, Adolfo Garcia-Sastre, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer Media name/outlet PR Newswire Country/Territory United States Date 3/03/21 Persons Mihaela Skobe, Adolfo Garcia-Sastre, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer Media name/outlet Morningstar.com Country/Territory United States Date 3/03/21 URL https://www.morningstar.com/news/pr-newswire/20210303ny96998/vaxalto-biotherapeutics-and-mount-sinai-enter-into-exclusive-license-agreement-for-the-development-and-commercialization-of-novel-immunotherapeutic-oncolytic-viruses-for-treatment-of-cancer Persons Mihaela Skobe, Adolfo Garcia-Sastre, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer Media name/outlet Finanzen.net Country/Territory Germany Date 3/03/21 URL https://www.finanzen.net/nachricht/aktien/vaxalto-biotherapeutics-and-mount-sinai-enter-into-exclusive-license-agreement-for-the-development-and-commercialization-of-novel-immunotherapeutic-oncolytic-viruses-for-treatment-of-cancer-9875328 Persons Mihaela Skobe, Adolfo Garcia-Sastre, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer Media name/outlet Finanzen.ch Country/Territory Switzerland Date 3/03/21 URL https://www.finanzen.ch/nachrichten/aktien/vaxalto-biotherapeutics-and-mount-sinai-enter-into-exclusive-license-agreement-for-the-development-and-commercialization-of-novel-immunotherapeutic-oncolytic-viruses-for-treatment-of-cancer-1030146041 Persons Mihaela Skobe, Adolfo Garcia-Sastre, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer Media name/outlet Yahoo! Finance Country/Territory United States Date 3/03/21 URL https://finance.yahoo.com/news/canadian-coast-guards-western-region-185700405.html Persons Mihaela Skobe, Adolfo Garcia-Sastre, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter i... Media name/outlet ADVFN Deutschland Country/Territory Germany Date 3/03/21 URL de.advfn.com/p.php?pid=nmona&article=84487753 Persons Mihaela Skobe, Adolfo Garcia-Sastre, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization.. Media name/outlet ADVFN UK Country/Territory United Kingdom Date 3/03/21 URL https://uk.advfn.com/stock-market/stock-news/84487753/vaxalto-biotherapeutics-and-mount-sinai-enter-into Persons Mihaela Skobe, Adolfo Garcia-Sastre, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer Media name/outlet TickerTech.com Country/Territory United States Date 3/03/21 URL www.tickertech.com/cgi/?a=news&ticker=a&w=&story=202103202103031008PR_NEWS_USPR_____NY96998 Persons Mihaela Skobe, Adolfo Garcia-Sastre, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer Media name/outlet TD Ameritrade Country/Territory United States Date 3/03/21 URL https://research.tdameritrade.com/grid/public/markets/news/story.asp?fromPage=results&docKey=100-062p4198 Persons Mihaela Skobe, Adolfo Garcia-Sastre, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive.. Media name/outlet ADVFN UK Country/Territory United Kingdom Date 3/03/21 URL https://uk.advfn.com/stock-market/stock-news/84487752/vaxalto-biotherapeutics-and-mount-sinai-enter-into Persons Mihaela Skobe, Adolfo Garcia-Sastre, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer Media name/outlet ProfitQuotes.com Country/Territory United States Date 3/03/21 URL www.profitquotes.com/cgi/?a=news&ticker=a&w=&story=202103202103031008PR_NEWS_USPR_____NY96998 Persons Mihaela Skobe, Adolfo Garcia-Sastre, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer Media name/outlet FirstWord Pharma Country/Territory United States Date 3/03/21 URL www.firstwordpharma.com/node/1806132 Persons Mihaela Skobe, Adolfo Garcia-Sastre, Peter Palese